Kolmar Korea Surges 31% in Week as Sunscreen Demand Boosts 2Q Earnings; FDA Approves New UV Filter

According to Korean securities firms, Kolmar Korea shares surged 31% in the week of June 26–July 2, bringing year-to-date gains to 38%, driven by strong suncare orders from top clients amid the summer season and expanded K-beauty distribution in North America and Europe.

Shinhan Investment Securities raised its price target to 130,000 Korean won (up from 123,000 won), with analysts projecting the company's Korean subsidiary operating profit margin to reach 15%, a record high. Additionally, the U.S. FDA approved Bemotrizinol, a new broad-spectrum organic sunscreen ingredient, for over-the-counter use on June 9—the first new active UV filter approved in 27 years—positioning Kolmar Korea to capture premium suncare orders from global cosmetics manufacturers.